Weize Yang
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 2
-
- Long-Term Effects of COVID-19 2
- Co-authors
- Xiaomin Luo (5 shared papers)Hongxia Xia (5 shared papers)Xiaojie Yan (2 shared papers)Benchao Wang (2 shared papers)Tangxi Guo (2 shared papers)Jun Xiong (1 shared paper)Lu Ye (1 shared paper)Yu Liu (1 shared paper)
- Journals
- Clinical Infectious Diseases (1 paper)Bioscience Reports (1 paper)Cell Biology International (1 paper)Disease Markers (1 paper)European Journal of Trauma and Emergency Surgery (1 paper)
- Partner nations
- China
In The Last Decade
Weize Yang
8 papers receiving 345 citations
Weize Yang's Hit Papers
Peers
Comparison fields: 5 of 63
- Infectious Diseases 185
- Neurology 75
- Critical Care and Intensive Care Medicine 14
- Rehabilitation 12
- Oncology 45
Countries citing papers authored by Weize Yang
This map shows the geographic impact of Weize Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weize Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weize Yang more than expected).
Fields of papers citing papers by Weize Yang
This network shows the impact of papers produced by Weize Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weize Yang. The network helps show where Weize Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Weize Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic Value of C-Reactive Protein in Patients With Coronavirus 2019 Hit paper breakdown → | 2020 | 291 |
| 2 | 2020 | 19 | |
| 3 | 2020 | 12 | |
| 4 | 2021 | 10 | |
| 5 | Guiding Effect of Serum Procalcitonin (PCT) on the Antibiotic Application to Patients with Sepsis. | 2017 | 7 |
| 6 | 2019 | 7 | |
| 7 | 2020 | 7 | |
| 8 | 2022 | 5 |
About Weize Yang
Weize Yang is a scholar working on Infectious Diseases, Neurology, Pathology and Forensic Medicine, Clinical Psychology and Epidemiology, having authored 8 papers that have together received 358 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (2 papers), Long-Term Effects of COVID-19 (2 papers), MicroRNA in disease regulation (1 paper), Endoplasmic Reticulum Stress and Disease (1 paper), Spinal Cord Injury Research (1 paper), COVID-19 and Mental Health (1 paper), Immune Response and Inflammation (1 paper) and Cancer-related molecular mechanisms research (1 paper). The work is most often cited by research in Infectious Diseases (185 citations), Neurology (75 citations), Critical Care and Intensive Care Medicine (14 citations), Rehabilitation (12 citations) and Oncology (45 citations). Weize Yang has collaborated with scholars based in China. Frequent co-authors include Xiaomin Luo, Hongxia Xia, Xiaojie Yan, Benchao Wang, Tangxi Guo, Jun Xiong, Lu Ye, Yu Liu, Wei Zhou and Bicheng Zhang. Their work appears in journals such as Clinical Infectious Diseases, Bioscience Reports, Cell Biology International, Disease Markers and European Journal of Trauma and Emergency Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.